2 results
Approved WMOCompleted
The aim of this study is to find out if a percutaneous angioplasty can be carried out safely in patients who received a therapeutic dose of Desirudin (Revasc®) before the operation.
Approved WMOWill not start
1. Assess the effectiveness of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2* System on lipid core burden in the study lipid core containing plaque segment(s) as assessed by…